Fresenius Medical Care AG & Co. KGaA (FME) — Strategic Asset Allocation Index
Fresenius Medical Care AG & Co. KGaA (FME) has a Strategic Asset Allocation Index of 10.0% as of June 2026. Strategic assets (PP&E of €- plus long-term investments of €1.36 Billion) total €1.36 Billion, measured against net assets of €13.53 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Fresenius Medical Care AG & Co. KGaA (FME) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Fresenius Medical Care AG & Co. KGaA Strategic Asset Allocation Index (2013–2025)
This chart shows how Fresenius Medical Care AG & Co. KGaA's Strategic Asset Allocation Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at 10.0%, representing strategic assets of €1.36 Billion against net assets of €13.53 Billion EUR. For live market cap and overall valuation, see market value of Fresenius Medical Care AG & Co. KGaA.
Annual Strategic Asset Allocation Index for Fresenius Medical Care AG & Co. KGaA (2013–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Fresenius Medical Care AG & Co. KGaA from 2013 to 2025, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Fresenius Medical Care AG & Co. KGaA book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 54.8% | €7.82 Billion | €6.50 Billion | €1.32 Billion | €14.28 Billion | ▼ -0.2 pp |
| 2024 | 55.0% | €8.68 Billion | €7.26 Billion | €1.42 Billion | €15.77 Billion | ▼ -3.7 pp |
| 2023 | 58.7% | €8.71 Billion | €7.45 Billion | €1.25 Billion | €14.83 Billion | ▼ -0.3 pp |
| 2022 | 59.0% | €9.11 Billion | €8.34 Billion | €773.72 Million | €15.45 Billion | ▼ -7.8 pp |
| 2021 | 66.8% | €9.34 Billion | €8.55 Billion | €786.90 Million | €13.98 Billion | ▼ -5.8 pp |
| 2020 | 72.6% | €8.95 Billion | €8.19 Billion | €761.11 Million | €12.33 Billion | ▲ +2.9 pp |
| 2019 | 69.6% | €9.21 Billion | €8.52 Billion | €696.87 Million | €13.23 Billion | ▲ +34.9 pp |
| 2018 | 34.8% | €4.49 Billion | €3.84 Billion | €649.78 Million | €12.90 Billion | ▼ -3.5 pp |
| 2017 | 38.2% | €4.14 Billion | €3.49 Billion | €647.01 Million | €10.83 Billion | ▼ -0.6 pp |
| 2016 | 38.8% | €4.23 Billion | €3.58 Billion | €645.85 Million | €10.89 Billion | ▼ -0.2 pp |
| 2015 | 39.0% | €3.74 Billion | €3.15 Billion | €593.62 Million | €9.60 Billion | ▼ -9.1 pp |
| 2014 | 48.1% | €3.97 Billion | €3.29 Billion | €676.82 Million | €8.25 Billion | ▼ -6.6 pp |
| 2013 | 54.7% | €3.76 Billion | €3.09 Billion | €664.45 Million | €6.87 Billion | — |